Background: Diabetes mellitus and breast cancer are both chronic diseases. Breast cancer in patients with diabetes is often diagnosed at an advanced stage and ha s worse prognosis. Aim of work: To investigate the clinicopathological factors, hormonal receptor status and molecular subtypes of breast cancer in diabetic breast cancer patients. Patients and methods: Records of patients presenting to the radiotherapy committee of the breast cancer clinic of Ain Shams University Hospital in the period between January 2017 and January 2018 were revised regarding age, presence of diabetes, presence of comorbidities, and type of the surgery performed. Pathological data such as: Tumor size (T), LN staging (LN), ER, PR, Her2/neu and Ki67 status were also recorded. Patients were divided into 2 groups : Group (I): those with diabetes and G roup (II): those without diabetes. Inclusion criteria were Breast cancer cases with proven pathological diagnosis, available IHC studies, clear record of comorbidity status, age > 18 years, cases who underwent upfront surgery. Exclusion criteria were metastatic cases, bilateral cases, cases with double primary, male breast cancer cases, and those with missing data for ER, PR and Her2/neu. Results: Retrieving data from the files of the patients that met the inclusion criteria in the allocated period revealed that 117 patients had diabetes (Group I) and 199 didn’t have the disease (Group II), There was a highly significant difference between both groups regarding the age as most of the patients with diabetes were above fifty years of age (84.6%) compared to only 44.7% of the patients without diabetes also the mean age of patients with diabetes was significantly higher (59 years) compared to 48 years of age for those without diabetes. Diabetes was associated with hypertension in most of the cases (69%). Comorbidities other than hypertension were recorded in 39 diabetic patients (33.3%) and 21 (10.6%) nondiabetic patients and the difference was statistically highly significant. In the diabetic group , the most encountered comorbidity was cardiac disease in 14.5% of patients. In the diabetic group , most of the patients underwent modified radical mastectomy (MRM) with a percentage of about 54.7% compared to 48.2% of patients for both groups respectively. Regarding pathological data apart from the finding that presence of diabetes was associated with more multiple tumors (p value: 0.013), no other statistically significant differences between both groups were found. Hormonal receptor status and molecular subtypes were also not affected by presence of diabetes in the studied breast cancer patients.
KeywordsBreast CancerDiabetes
Zhao, X.-B. and Ren, G.-S. (2016) Diabetes Mellitus and Prognosis in Women with Breast Cancer. Medicine, 95, e5602.
Forouzanfar, M.H., Foreman, K.J., Delossantos, A.M., Lozano, R., Lopez, A.D., Murray, C.J. and Naghavi, M. (2011) Breast and Cervical Cancer in 187 Countries between 1980 and 2010: A Systematic Analysis. The Lancet, 378, 1461-1484. https://doi.org/10.1016/S0140-6736(11)61351-2
Ibrahim, A.S., Khaled, H.M., Mikhail, N.N., Baraka, H. and Kamel, H. (2014) Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program. Journal of Cancer Epidemiology, 2014, Article ID: 437971. https://doi.org/10.1155/2014/437971
Lam, E.K.K., Batty, G.D., Huxley, R.R., Martiniuk, A.L.C., Barzi, F., Lam, T.H., Lawes, C.M.M., Giles, G.G., Welborn, T., Ueshima, H., Tamakoshi, A., Woo, J., Kim, H.C., Fang, X., Czernichow, S. and Woodward, M. (2011) Asia Pacific Cohort Studies Collaboration. Associations of Diabetes Mellitus with Site-Specific Cancer Mortality in the Asia-Pacific Region. Annals of Oncology, 22, 730-738. https://doi.org/10.1093/annonc/mdq405
Liao, S., Li, J., Wei, W., Wang, L., Zhang, Y., Li, J., Wang, C. and Sun, S. (2011) Association between Diabetes Mellitus and Breast Cancer Risk: A Meta-Analysis of the Literature. Asian Pacific Journal of Cancer Prevention, 12, 1061-1065.
Starup-Linde, J., Karlstad, O., Eriksen, S.A., et al. (2013) CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants—A Systematic Review and a Meta-Analysis. Current Drug Safety, 8, 296-332. https://doi.org/10.2174/15748863113086660071
Luo, J., Virnig, B., Hendryx, M., Wen, S., et al. (2014) Diabetes, Diabetes Treatment and Breast Cancer Prognosis. Breast Cancer Research and Treatment, 148, 153-162. https://doi.org/10.1007/s10549-014-3146-9
Peairs, K.S., Barone, B.B., Snyder, C.F., Yeh, H.C., Stein, K.B., Derr, R.L., Brancati, F.L. and Wolff, A.C. (2011) Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis. Journal of Clinical Oncology, 29, 40-46. https://doi.org/10.1200/JCO.2009.27.3011
Flores-López, L.A., Martínez-Hernández, M.G., Viedma-Rodríguez, R., Díaz-Flores, M. and Baiza-Gutman, L.A. (2016) High Glucose and Insulin Enhance uPA Expression, ROS Formation and Invasiveness in Breast Cancer-Derived Cells. Cellular Oncology, 39, 365-378. https://doi.org/10.1007/s13402-016-0282-8
Clinicopathological
Molecular Subtypes Running Head: Diabetes in Breast Cancer Patients
Bronsveld, H.K., Jensen, V., Vahl, P., De Bruin, M.L., Cornelissen, S., Sanders, J., Auvinen, A., Haukka, J., Andersen, M., Vestergaard, P. and Schmidt, M.K. (2017) Diabetes and Breast Cancer Subtypes. PLoS ONE, 12, e0170084. https://doi.org/10.1371/journal.pone.0170084
Chen, H., Cook, L.S., Tang, M.C., Hill, D.A., Wiggins, C.L. and Li, C.I. (2019) Relationship between Diabetes and Diabetes Medications and Risk of Different Molecular Subtypes of Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention, 28, 1802-1808. https://doi.org/10.1158/1055-9965.EPI-19-0291
Gallagher, E.J. and LeRoith, D. (2010) The Proliferating Role of Insulin and Insulin-Like Growth Factors in Cancer. Trends in Endocrinology & Metabolism, 21, 610-618. https://doi.org/10.1016/j.tem.2010.06.007
Davison, Z., de Blacquière, G.E., Westley, B.R. and May, F.E. (2011) Insulin-Like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy. Neoplasia, 13, 504-515. https://doi.org/10.1593/neo.101590
Yang, X.R., Chang-Claude, J., Goode, E.L., et al. (2011) Associations of Breast Cancer Risk Factors with Tumor Subtypes: A Pooled Analysis from the Breast Cancer Association Consortium Studies. Journal of the National Cancer Institute, 103, 250-263. https://doi.org/10.1093/jnci/djq526
Goldhirsch, A., Winer, E.P., Coates, A.S., Gelber, R.D., Piccart-Gebhart, M., Thürlimann, B. and Senn, H.J. (2013) Personalizing the Treatment of Women with Early Breast Cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Annals of Oncology, 24, 2206-2223.
Hou, G., Zhang, S., Zhang, X., Wang, P., Hao, X. and Zhang, J. (2013) Clinical Pathological Characteristics and Prognostic Analysis of 1,013 Breast Cancer Patients with Diabetes. Breast Cancer Research and Treatment, 137, 807-816. https://doi.org/10.1007/s10549-012-2404-y
Palmer, J.R., Castro-Webb, N., Bertrand, K., Bethea, T.N. and Denis, G.V. (2017) Type II Diabetes and Incidence of Estrogen Receptor Negative Breast Cancer in African American Women. Cancer Research, 77, 6462-6469. https://doi.org/10.1158/0008-5472.CAN-17-1903
Michels, K.B., Solomon, C.G., Hu, F.B., Rosner, B.A., Hankinson, S.E., Colditz, G.A. and Manson, J.E. (2003) Type 2 Diabetes and Subsequent Incidence of Breast Cancer in the Nurses’ Health Study. Diabetes Care, 26, 1752-1758. https://doi.org/10.2337/diacare.26.6.1752
Wolf, I., Sadetzki, S., Gluck, I., Oberman, B., Ben-David, M., Papa, M.Z., Catane, R. and Kaufman, B. (2006) Association between Diabetes Mellitus and Adverse Characteristics of Breast Cancer at Presentation. European Journal of Cancer, 42, 1077-1082. https://doi.org/10.1016/j.ejca.2006.01.027
Ali, A., Mohamed, M., Khattab, N., Tabl, A. and Emam, R. (2020) Relationship between Diabetes Mellitus and Clinicopathological Stages of Breast Cancer at Diagnosis. Benha Medical Journal, 37, 68-80.
Rose, D.P., Komninou, D. and Stephenson, G.D. (2004) Obesity, Adipocytokines, and Insulin Resistance in Breast Cancer. Obesity Reviews, 5, 153-165. https://doi.org/10.1111/j.1467-789X.2004.00142.x
Hartman, Z.C., Poage, G.M., den Hollander, P., Tsimelzon, A., Hill, J., Panupinthu, N., Zhang, Y., Mazumdar, A., Hilsenbeck, S.G., Mills, G.B. and Brown, P.H. (2013) Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8. Cancer Research, 73, 3470-3480. https://doi.org/10.1158/0008-5472.CAN-12-4524-T
Gross, A.L., Blot, W.J. and Visvanathan, K. (2019) Type II Diabetes and Subtype-Specific Breast Cancer Risk in Medically Underserved Black and White Women. Proceedings of the 2018 San Antonio Breast Cancer Symposium, San Antonio, 4-8 December 2018, San Antonio, 5-16-12.
Maskarinec, G., Jacobs, S., Park, S.Y., Haiman, C.A., Setiawan, V.W., Wilkens, L.R. and Le Marchand, L. (2017) Type II Diabetes, Obesity, and Breast Cancer Risk: The Multiethnic Cohort. Cancer Epidemiology, Biomarkers & Prevention, 26, 854-861. https://doi.org/10.1158/1055-9965.EPI-16-0789
Crispo, A., Augustin, L.S., Grimaldi, M., Nocerino, F., Giudice, A., Cavalcanti, E., Di Bonito, M., Botti, G., De Laurentiis, M., Rinaldo, M., Esposito, E., Riccardi, G., Amore, A., Libra, M., Ciliberto, G., Jenkins, D.J. and Montella, M. (2017) Risk Differences between Prediabetes and Diabetes According to Breast Cancer Molecular Subtypes. Journal of Cellular Physiology, 232, 1144-1150. https://doi.org/10.1002/jcp.25579
Garcia-Esquinas, E., Guino, E., Castano-Vinyals, G., Perez-Gomez, B., Llorca, J., Altzibar, J.M., et al. (2016) Association of Diabetes and Diabetes Treatment with Incidence of Breast Cancer. Acta Diabetologica, 53, 99-107. https://doi.org/10.1007/s00592-015-0756-6
Millikan, R.C., Newman, B., Tse, C.K., Moorman, P.G., Conway, K., Dressler, L.G., et al. (2008) Epidemiology of Basal-Like Breast Cancer. Breast Cancer Research and Treatment, 109, 123-139. https://doi.org/10.1007/s10549-007-9632-6
Lara-Medina, F., Perez-Sanchez, V., Saavedra-Perez, D., Blake-Cerda, M., Arce, C., Motola-Kuba, D., et al. (2011) Triple-Negative Breast Cancer in Hispanic Patients: High Prevalence, Poor Prognosis, and Association with Menopausal Status, Body Mass Index, and Parity. Cancer, 117, 3658-3669. https://doi.org/10.1002/cncr.25961